Clean Yield Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-57
Closed -$7.31K 420
2025
Q3
$7.31K Sell
57
-63
-53% -$7.69K ﹤0.01% 337
2025
Q2
$14.5K Hold
120
﹤0.01% 284
2025
Q1
$13.4K Sell
120
-254
-68% -$27K ﹤0.01% 301
2024
Q4
$36.4K Hold
374
0.01% 257
2024
Q3
$43K Buy
+374
New +$42.4K 0.01% 240
2020
Q4
Sell
-26
Closed -$2K 434
2020
Q3
$2K Buy
+26
New +$2.25K ﹤0.01% 357
2020
Q1
Sell
-11
Closed -$1K 404
2019
Q4
$1K Sell
11
-233
-95% -$20.9K ﹤0.01% 345
2019
Q3
$21K Buy
244
+85
+53% +$7.63K 0.01% 261
2019
Q2
$15K Buy
+159
New +$13.5K 0.01% 281
2017
Q2
Sell
-279
Closed -$19K 224
2017
Q1
$19K Buy
+279
New +$18.6K 0.01% 255
2016
Q4
Sell
-290
Closed -$21K 229
2016
Q3
$21K Buy
290
+67
+30% +$4.88K 0.01% 251
2016
Q2
$17K Hold
223
0.01% 240
2016
Q1
$15K Buy
+223
New +$15.2K 0.01% 241
2015
Q2
Sell
-433
Closed -$38K 234
2015
Q1
$38K Buy
+433
New +$38.4K 0.02% 194

Other funds holding NVS

Clean Yield Group's NVS Position: Q4 2025 in Review

Clean Yield Group sold out of Novartis (NVS) in Q4 2025, closing a stake of 57 shares — an estimated $7.31K sold.

Clean Yield Group first reported a position in NVS in Q1 2015 and held it in 14 quarters. The position peaked at $43K in Q3 2024. 1,509 funds tracked by Wall St. Rank hold NVS as of Q4 2025.

  • Clean Yield Group reported no remaining Novartis position as of Q4 2025 after selling out during the quarter.
  • Clean Yield Group sold 57 Novartis shares in Q4 2025, an estimated $7.31K.
  • Clean Yield Group first reported a position in Novartis in Q1 2015 and held it in 14 quarters.
  • Clean Yield Group's Novartis position peaked at $43K in Q3 2024.
  • 1,509 funds tracked by Wall St. Rank held Novartis as of Q4 2025.

Based on Clean Yield Group's 13F filing for Q4 2025, filed 26 Jan 2026.